APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kangerxin Capsules

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Kangerxin Capsules Industry Growth and Trends Forecast to 2032

26 December 2025124 pages

Choose your research edition.

Industry ResearchKangerxin Capsules Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Kangerxin Capsules Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Kangerxin Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kangerxin Capsules Market Outlook and Growth Opportunities 2026218 pages · $4,250 USDMarket Analysis & ForecastGlobal Kangerxin Capsules Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global Kangerxin Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kangerxin Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kangerxin Capsules include Changsha Dongfeng Pharmaceutical Co., Ltd., Xinjiang Quan'an Pharmaceutical Co., Ltd., Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd., Weihai Norda Pharmaceutical Group Co., Ltd., Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd., Suzhou Huabao Pharmaceutical Co., Ltd., Shandong Buchang Shenzhou Pharmaceutical Co., Ltd., Panjin Hengchanglong Pharmaceutical Co., Ltd. and Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kangerxin Capsules market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kangerxin Capsules market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kangerxin Capsules market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kangerxin Capsules.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kangerxin Capsules market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kangerxin Capsules Market by Company

Changsha Dongfeng Pharmaceutical Co., Ltd.

Xinjiang Quan'an Pharmaceutical Co., Ltd.

Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.

Weihai Norda Pharmaceutical Group Co., Ltd.

Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.

Suzhou Huabao Pharmaceutical Co., Ltd.

Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.

Panjin Hengchanglong Pharmaceutical Co., Ltd.

Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.

Liaoning Keji Pharmaceutical Co., Ltd.

Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.

Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.

Jilin Zhongyan Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.

Henan Xinsifang Pharmaceutical Co., Ltd.

Harbin Meijun Pharmaceutical Co., Ltd.

Guizhou Yuancheng Pharmaceutical Co., Ltd.

Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.

Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.

Guangdong Shaxi Pharmaceutical Co., Ltd.

Beijing Baoshutang Technology Pharmaceutical Co., Ltd.

Kangerxin Capsules Segment by Type

0.4g×12 Capsules×2 Plates

0.4g×12 Capsules×4 Plates

Kangerxin Capsules Segment by Application

Hospital

Clinic

Other

Kangerxin Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kangerxin Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kangerxin Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kangerxin Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kangerxin Capsules manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kangerxin Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.4g×12 Capsules×2 Plates Table 2. Major Company of 0.4g×12 Capsules×4 Plates Table 3. Global Kangerxin Capsules Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 5. Global Kangerxin Capsules Sales Market Share in Volume by Type (2021-2026) Table 6. Global Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 7. Global Kangerxin Capsules Sales Market Share in Value by Type (2021-2026) Table 8. Global Kangerxin Capsules Price by Type (2021-2026) & (US$/Unit) Table 9. Global Kangerxin Capsules Sales by Type (2027-2032) & (K Units) Table 10. Global Kangerxin Capsules Sales Market Share in Volume by Type (2027-2032) Table 11. Global Kangerxin Capsules Sales by Type (2027-2032) & (US$ Million) Table 12. Global Kangerxin Capsules Sales Market Share in Value by Type (2027-2032) Table 13. Global Kangerxin Capsules Price by Type (2027-2032) & (US$/Unit) Table 14. North America Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 15. North America Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 17. Europe Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 21. Latin America Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Kangerxin Capsules Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Kangerxin Capsules Sales by Type (2021-2026) & (US$ Million) Table 24. Kangerxin Capsules Industry Trends Table 25. Kangerxin Capsules Industry Drivers Table 26. Kangerxin Capsules Industry Opportunities and Challenges Table 27. Kangerxin Capsules Industry Restraints Table 28. Global Kangerxin Capsules Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Kangerxin Capsules Revenue Market Share by Company (2021-2026) Table 30. Global Kangerxin Capsules Sales by Company (2021-2026) & (K Units) Table 31. Global Kangerxin Capsules Sales Share by Company (2021-2026) Table 32. Global Kangerxin Capsules Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Kangerxin Capsules Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Kangerxin Capsules Major Company Production Sites and Headquarters Table 35. Global Kangerxin Capsules Company, Product Type & Application Table 36. Global Kangerxin Capsules Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Kangerxin Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Kangerxin Capsules Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Kangerxin Capsules Sales by Region (2021-2026) & (K Units) Table 41. Global Kangerxin Capsules Sales Market Share in Volume by Region (2021-2026) Table 42. Global Kangerxin Capsules Sales by Region (2021-2026) & (US$ Million) Table 43. Global Kangerxin Capsules Sales Market Share in Value by Region (2021-2026) Table 44. Global Kangerxin Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Kangerxin Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Kangerxin Capsules Sales Market Share in Volume by Region (2027-2032) Table 47. Global Kangerxin Capsules Sales by Region (2027-2032) & (US$ Million) Table 48. Global Kangerxin Capsules Sales Market Share in Value by Region (2027-2032) Table 49. Global Kangerxin Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Kangerxin Capsules Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 52. Global Kangerxin Capsules Sales Market Share in Volume by Application (2021-2026) Table 53. Global Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 54. Global Kangerxin Capsules Sales Market Share in Value by Application (2021-2026) Table 55. Global Kangerxin Capsules Price by Application (2021-2026) & (US$/Unit) Table 56. Global Kangerxin Capsules Sales by Application (2027-2032) & (K Units) Table 57. Global Kangerxin Capsules Sales Market Share in Volume by Application (2027-2032) Table 58. Global Kangerxin Capsules Sales by Application (2027-2032) & (US$ Million) Table 59. Global Kangerxin Capsules Sales Market Share in Value by Application (2027-2032) Table 60. Global Kangerxin Capsules Price by Application (2027-2032) & (US$/Unit) Table 61. North America Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 62. North America Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 64. Europe Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 68. Latin America Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Kangerxin Capsules Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Kangerxin Capsules Sales by Application (2021-2026) & (US$ Million) Table 71. Changsha Dongfeng Pharmaceutical Co., Ltd. Company Information Table 72. Changsha Dongfeng Pharmaceutical Co., Ltd. Business Overview Table 73. Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 75. Changsha Dongfeng Pharmaceutical Co., Ltd. Recent Development Table 76. Xinjiang Quan'an Pharmaceutical Co., Ltd. Company Information Table 77. Xinjiang Quan'an Pharmaceutical Co., Ltd. Business Overview Table 78. Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 80. Xinjiang Quan'an Pharmaceutical Co., Ltd. Recent Development Table 81. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information Table 82. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview Table 83. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 85. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Development Table 86. Weihai Norda Pharmaceutical Group Co., Ltd. Company Information Table 87. Weihai Norda Pharmaceutical Group Co., Ltd. Business Overview Table 88. Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Product Portfolio Table 90. Weihai Norda Pharmaceutical Group Co., Ltd. Recent Development Table 91. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Company Information Table 92. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Business Overview Table 93. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Product Portfolio Table 95. Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Recent Development Table 96. Suzhou Huabao Pharmaceutical Co., Ltd. Company Information Table 97. Suzhou Huabao Pharmaceutical Co., Ltd. Business Overview Table 98. Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 100. Suzhou Huabao Pharmaceutical Co., Ltd. Recent Development Table 101. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information Table 102. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview Table 103. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 105. Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Development Table 106. Panjin Hengchanglong Pharmaceutical Co., Ltd. Company Information Table 107. Panjin Hengchanglong Pharmaceutical Co., Ltd. Business Overview Table 108. Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 110. Panjin Hengchanglong Pharmaceutical Co., Ltd. Recent Development Table 111. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information Table 112. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview Table 113. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 115. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Development Table 116. Liaoning Keji Pharmaceutical Co., Ltd. Company Information Table 117. Liaoning Keji Pharmaceutical Co., Ltd. Business Overview Table 118. Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 120. Liaoning Keji Pharmaceutical Co., Ltd. Recent Development Table 121. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information Table 122. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Business Overview Table 123. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 125. Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Development Table 126. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information Table 127. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview Table 128. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 130. Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Development Table 131. Jilin Zhongyan Pharmaceutical Co., Ltd. Company Information Table 132. Jilin Zhongyan Pharmaceutical Co., Ltd. Business Overview Table 133. Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 135. Jilin Zhongyan Pharmaceutical Co., Ltd. Recent Development Table 136. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 137. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 138. Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 140. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 141. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information Table 142. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview Table 143. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 145. China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Development Table 146. Henan Xinsifang Pharmaceutical Co., Ltd. Company Information Table 147. Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview Table 148. Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 150. Henan Xinsifang Pharmaceutical Co., Ltd. Recent Development Table 151. Harbin Meijun Pharmaceutical Co., Ltd. Company Information Table 152. Harbin Meijun Pharmaceutical Co., Ltd. Business Overview Table 153. Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 155. Harbin Meijun Pharmaceutical Co., Ltd. Recent Development Table 156. Guizhou Yuancheng Pharmaceutical Co., Ltd. Company Information Table 157. Guizhou Yuancheng Pharmaceutical Co., Ltd. Business Overview Table 158. Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 160. Guizhou Yuancheng Pharmaceutical Co., Ltd. Recent Development Table 161. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Company Information Table 162. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Business Overview Table 163. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 165. Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Recent Development Table 166. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Company Information Table 167. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Business Overview Table 168. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Product Portfolio Table 170. Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Recent Development Table 171. Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information Table 172. Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview Table 173. Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 175. Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Development Table 176. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Company Information Table 177. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Business Overview Table 178. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 179. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio Table 180. Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Recent Development Table 181. North America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 182. North America Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 183. North America Kangerxin Capsules Sales Market Share by Country (2021-2026) Table 184. North America Kangerxin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 185. North America Kangerxin Capsules Sales Market Share Forecast by Country (2027-2032) Table 186. North America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. North America Kangerxin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 188. North America Kangerxin Capsules Market Share by Country (2021-2026) Table 189. North America Kangerxin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. North America Kangerxin Capsules Market Share Forecast by Country (2027-2032) Table 191. Europe Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 192. Europe Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 193. Europe Kangerxin Capsules Sales Market Share by Country (2021-2026) Table 194. Europe Kangerxin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 195. Europe Kangerxin Capsules Sales Market Share Forecast by Country (2027-2032) Table 196. Europe Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 197. Europe Kangerxin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 198. Europe Kangerxin Capsules Market Share by Country (2021-2026) Table 199. Europe Kangerxin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 200. Europe Kangerxin Capsules Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 203. Asia-Pacific Kangerxin Capsules Sales Market Share by Country (2021-2026) Table 204. Asia-Pacific Kangerxin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 205. Asia-Pacific Kangerxin Capsules Sales Market Share Forecast by Country (2027-2032) Table 206. Asia-Pacific Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 207. Asia-Pacific Kangerxin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 208. Asia-Pacific Kangerxin Capsules Market Share by Country (2021-2026) Table 209. Asia-Pacific Kangerxin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 210. Asia-Pacific Kangerxin Capsules Market Share Forecast by Country (2027-2032) Table 211. Latin America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 212. Latin America Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 213. Latin America Kangerxin Capsules Sales Market Share by Country (2021-2026) Table 214. Latin America Kangerxin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 215. Latin America Kangerxin Capsules Sales Market Share Forecast by Country (2027-2032) Table 216. Latin America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 217. Latin America Kangerxin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 218. Latin America Kangerxin Capsules Market Share by Country (2021-2026) Table 219. Latin America Kangerxin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 220. Latin America Kangerxin Capsules Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Kangerxin Capsules Sales by Country (2021-2026) & (K Units) Table 223. Middle East and Africa Kangerxin Capsules Sales Market Share by Country (2021-2026) Table 224. Middle East and Africa Kangerxin Capsules Sales Forecast by Country (2027-2032) & (K Units) Table 225. Middle East and Africa Kangerxin Capsules Sales Market Share Forecast by Country (2027-2032) Table 226. Middle East and Africa Kangerxin Capsules Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 227. Middle East and Africa Kangerxin Capsules Market Size by Country (2021-2026) & (US$ Million) Table 228. Middle East and Africa Kangerxin Capsules Market Share by Country (2021-2026) Table 229. Middle East and Africa Kangerxin Capsules Market Size Forecast by Country (2027-2032) & (US$ Million) Table 230. Middle East and Africa Kangerxin Capsules Market Share Forecast by Country (2027-2032) Table 231. Key Raw Materials Table 232. Raw Materials Key Suppliers Table 233. Kangerxin Capsules Distributors List Table 234. Kangerxin Capsules Customers List Table 235. Research Programs/Design for This Report Table 236. Authors List of This Report Table 237. Secondary Sources Table 238. Primary Sources List of Figures Figure 1. Kangerxin Capsules Image Figure 2. Global Kangerxin Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kangerxin Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Kangerxin Capsules Sales (2021-2032) & (K Units) Figure 5. 0.4g×12 Capsules×2 Plates Image Figure 6. Global 0.4g×12 Capsules×2 Plates Sales YoY Growth (2021-2032) & (K Units) Figure 7. 0.4g×12 Capsules×4 Plates Image Figure 8. Global 0.4g×12 Capsules×4 Plates Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Kangerxin Capsules Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Kangerxin Capsules Market Share by Type 2025 VS 2032 Figure 11. North America Kangerxin Capsules Sales Market Share in Volume by Type in 2025 Figure 12. North America Kangerxin Capsules Sales Market Share in Value by Type in 2025 Figure 13. Europe Kangerxin Capsules Sales Market Share in Volume by Type in 2025 Figure 14. Europe Kangerxin Capsules Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Kangerxin Capsules Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Kangerxin Capsules Sales Market Share in Value by Type in 2025 Figure 17. Latin America Kangerxin Capsules Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Kangerxin Capsules Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Kangerxin Capsules Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Kangerxin Capsules Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Kangerxin Capsules Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Clinic Image Figure 26. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Kangerxin Capsules Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Kangerxin Capsules Market Share by Application 2025 VS 2032 Figure 31. North America Kangerxin Capsules Sales Market Share in Volume by Application in 2025 Figure 32. North America Kangerxin Capsules Sales Market Share in Value by Application in 2025 Figure 33. Europe Kangerxin Capsules Sales Market Share in Volume by Application in 2025 Figure 34. Europe Kangerxin Capsules Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Kangerxin Capsules Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Kangerxin Capsules Sales Market Share in Value by Application in 2025 Figure 37. Latin America Kangerxin Capsules Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Kangerxin Capsules Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Kangerxin Capsules Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Kangerxin Capsules Sales Market Share in Value by Application in 2025 Figure 41. North America Kangerxin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Kangerxin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Kangerxin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Kangerxin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Kangerxin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Kangerxin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Kangerxin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Kangerxin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Kangerxin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Kangerxin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Kangerxin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Kangerxin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Kangerxin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Kangerxin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Kangerxin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Kangerxin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Kangerxin Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Kangerxin Capsules Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Kangerxin Capsules Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Kangerxin Capsules Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Kangerxin Capsules Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Kangerxin Capsules Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • 0.4g×12 Capsules×2 Plates
  • 0.4g×12 Capsules×4 Plates
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Changsha Dongfeng Pharmaceutical Co., Ltd.
  • Xinjiang Quan'an Pharmaceutical Co., Ltd.
  • Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  • Weihai Norda Pharmaceutical Group Co., Ltd.
  • Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.
  • Suzhou Huabao Pharmaceutical Co., Ltd.
  • Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  • Panjin Hengchanglong Pharmaceutical Co., Ltd.
  • Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  • Liaoning Keji Pharmaceutical Co., Ltd.
  • Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
  • Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  • Jilin Zhongyan Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.
  • China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  • Henan Xinsifang Pharmaceutical Co., Ltd.
  • Harbin Meijun Pharmaceutical Co., Ltd.
  • Guizhou Yuancheng Pharmaceutical Co., Ltd.
  • Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.
  • Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.
  • Guangdong Shaxi Pharmaceutical Co., Ltd.
  • Beijing Baoshutang Technology Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kangerxin Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kangerxin Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kangerxin Capsules Market by Type
  6. 1.3.1 0.4g×12 Capsules×2 Plates
  7. 1.3.2 0.4g×12 Capsules×4 Plates
  8. 1.4 Global Kangerxin Capsules Market Size by Type
  9. 1.4.1 Global Kangerxin Capsules Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Kangerxin Capsules Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Kangerxin Capsules Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Kangerxin Capsules Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Kangerxin Capsules Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Kangerxin Capsules Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Kangerxin Capsules Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Kangerxin Capsules Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kangerxin Capsules Industry Trends
  2. 2.2 Kangerxin Capsules Industry Drivers
  3. 2.3 Kangerxin Capsules Industry Opportunities and Challenges
  4. 2.4 Kangerxin Capsules Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kangerxin Capsules Revenue (2021-2026)
  2. 3.2 Global Top Players by Kangerxin Capsules Sales (2021-2026)
  3. 3.3 Global Top Players by Kangerxin Capsules Price (2021-2026)
  4. 3.4 Global Kangerxin Capsules Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kangerxin Capsules Major Company Production Sites & Headquarters
  6. 3.6 Global Kangerxin Capsules Company, Product Type & Application
  7. 3.7 Global Kangerxin Capsules Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kangerxin Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kangerxin Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kangerxin Capsules Tier 1, Tier 2, and Tier 3
4 Kangerxin Capsules Regional Status and Outlook
  1. 4.1 Global Kangerxin Capsules Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kangerxin Capsules Historic Market Size by Region
  3. 4.2.1 Global Kangerxin Capsules Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kangerxin Capsules Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kangerxin Capsules Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kangerxin Capsules Forecasted Market Size by Region
  7. 4.3.1 Global Kangerxin Capsules Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kangerxin Capsules Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kangerxin Capsules Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kangerxin Capsules by Application
  1. 5.1 Kangerxin Capsules Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Kangerxin Capsules Market Size by Application
  6. 5.2.1 Global Kangerxin Capsules Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Kangerxin Capsules Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Kangerxin Capsules Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Kangerxin Capsules Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Kangerxin Capsules Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Kangerxin Capsules Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Kangerxin Capsules Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Kangerxin Capsules Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Changsha Dongfeng Pharmaceutical Co., Ltd.
  2. 6.1.1 Changsha Dongfeng Pharmaceutical Co., Ltd. Company Information
  3. 6.1.2 Changsha Dongfeng Pharmaceutical Co., Ltd. Business Overview
  4. 6.1.3 Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Changsha Dongfeng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  6. 6.1.5 Changsha Dongfeng Pharmaceutical Co., Ltd. Recent Developments
  7. 6.2 Xinjiang Quan'an Pharmaceutical Co., Ltd.
  8. 6.2.1 Xinjiang Quan'an Pharmaceutical Co., Ltd. Company Information
  9. 6.2.2 Xinjiang Quan'an Pharmaceutical Co., Ltd. Business Overview
  10. 6.2.3 Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Xinjiang Quan'an Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  12. 6.2.5 Xinjiang Quan'an Pharmaceutical Co., Ltd. Recent Developments
  13. 6.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  14. 6.3.1 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  18. 6.3.5 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Weihai Norda Pharmaceutical Group Co., Ltd.
  20. 6.4.1 Weihai Norda Pharmaceutical Group Co., Ltd. Company Information
  21. 6.4.2 Weihai Norda Pharmaceutical Group Co., Ltd. Business Overview
  22. 6.4.3 Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Weihai Norda Pharmaceutical Group Co., Ltd. Kangerxin Capsules Product Portfolio
  24. 6.4.5 Weihai Norda Pharmaceutical Group Co., Ltd. Recent Developments
  25. 6.5 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd.
  26. 6.5.1 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Company Information
  27. 6.5.2 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Business Overview
  28. 6.5.3 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Kangerxin Capsules Product Portfolio
  30. 6.5.5 Taiji Group Chongqing Traditional Chinese Medicine Factory No. 2 Co., Ltd. Recent Developments
  31. 6.6 Suzhou Huabao Pharmaceutical Co., Ltd.
  32. 6.6.1 Suzhou Huabao Pharmaceutical Co., Ltd. Company Information
  33. 6.6.2 Suzhou Huabao Pharmaceutical Co., Ltd. Business Overview
  34. 6.6.3 Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Suzhou Huabao Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  36. 6.6.5 Suzhou Huabao Pharmaceutical Co., Ltd. Recent Developments
  37. 6.7 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd.
  38. 6.7.1 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Company Information
  39. 6.7.2 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Business Overview
  40. 6.7.3 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  42. 6.7.5 Shandong Buchang Shenzhou Pharmaceutical Co., Ltd. Recent Developments
  43. 6.8 Panjin Hengchanglong Pharmaceutical Co., Ltd.
  44. 6.8.1 Panjin Hengchanglong Pharmaceutical Co., Ltd. Company Information
  45. 6.8.2 Panjin Hengchanglong Pharmaceutical Co., Ltd. Business Overview
  46. 6.8.3 Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Panjin Hengchanglong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  48. 6.8.5 Panjin Hengchanglong Pharmaceutical Co., Ltd. Recent Developments
  49. 6.9 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  50. 6.9.1 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information
  51. 6.9.2 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview
  52. 6.9.3 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  54. 6.9.5 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Developments
  55. 6.10 Liaoning Keji Pharmaceutical Co., Ltd.
  56. 6.10.1 Liaoning Keji Pharmaceutical Co., Ltd. Company Information
  57. 6.10.2 Liaoning Keji Pharmaceutical Co., Ltd. Business Overview
  58. 6.10.3 Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Liaoning Keji Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  60. 6.10.5 Liaoning Keji Pharmaceutical Co., Ltd. Recent Developments
  61. 6.11 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
  62. 6.11.1 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Company Information
  63. 6.11.2 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Business Overview
  64. 6.11.3 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  66. 6.11.5 Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd. Recent Developments
  67. 6.12 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd.
  68. 6.12.1 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Company Information
  69. 6.12.2 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Business Overview
  70. 6.12.3 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  72. 6.12.5 Jiangxi Kangenbei Tianshikang Pharmaceutical Co., Ltd. Recent Developments
  73. 6.13 Jilin Zhongyan Pharmaceutical Co., Ltd.
  74. 6.13.1 Jilin Zhongyan Pharmaceutical Co., Ltd. Company Information
  75. 6.13.2 Jilin Zhongyan Pharmaceutical Co., Ltd. Business Overview
  76. 6.13.3 Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Jilin Zhongyan Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  78. 6.13.5 Jilin Zhongyan Pharmaceutical Co., Ltd. Recent Developments
  79. 6.14 Jilin Hengjin Pharmaceutical Co., Ltd.
  80. 6.14.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  81. 6.14.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  82. 6.14.3 Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Jilin Hengjin Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  84. 6.14.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
  85. 6.15 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd.
  86. 6.15.1 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Company Information
  87. 6.15.2 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Business Overview
  88. 6.15.3 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  90. 6.15.5 China Resources Sanjiu (Beijing) Pharmaceutical Co., Ltd. Recent Developments
  91. 6.16 Henan Xinsifang Pharmaceutical Co., Ltd.
  92. 6.16.1 Henan Xinsifang Pharmaceutical Co., Ltd. Company Information
  93. 6.16.2 Henan Xinsifang Pharmaceutical Co., Ltd. Business Overview
  94. 6.16.3 Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Henan Xinsifang Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  96. 6.16.5 Henan Xinsifang Pharmaceutical Co., Ltd. Recent Developments
  97. 6.17 Harbin Meijun Pharmaceutical Co., Ltd.
  98. 6.17.1 Harbin Meijun Pharmaceutical Co., Ltd. Company Information
  99. 6.17.2 Harbin Meijun Pharmaceutical Co., Ltd. Business Overview
  100. 6.17.3 Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Harbin Meijun Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  102. 6.17.5 Harbin Meijun Pharmaceutical Co., Ltd. Recent Developments
  103. 6.18 Guizhou Yuancheng Pharmaceutical Co., Ltd.
  104. 6.18.1 Guizhou Yuancheng Pharmaceutical Co., Ltd. Company Information
  105. 6.18.2 Guizhou Yuancheng Pharmaceutical Co., Ltd. Business Overview
  106. 6.18.3 Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Guizhou Yuancheng Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  108. 6.18.5 Guizhou Yuancheng Pharmaceutical Co., Ltd. Recent Developments
  109. 6.19 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd.
  110. 6.19.1 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Company Information
  111. 6.19.2 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Business Overview
  112. 6.19.3 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  114. 6.19.5 Guangzhou Xiaoqiling Pharmaceutical Co., Ltd. Recent Developments
  115. 6.20 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd.
  116. 6.20.1 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Company Information
  117. 6.20.2 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Business Overview
  118. 6.20.3 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Kangerxin Capsules Product Portfolio
  120. 6.20.5 Guangzhou Baiyunshan Chenliji Pharmaceutical Factory Co., Ltd. Recent Developments
  121. 6.21 Guangdong Shaxi Pharmaceutical Co., Ltd.
  122. 6.21.1 Guangdong Shaxi Pharmaceutical Co., Ltd. Company Information
  123. 6.21.2 Guangdong Shaxi Pharmaceutical Co., Ltd. Business Overview
  124. 6.21.3 Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Guangdong Shaxi Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  126. 6.21.5 Guangdong Shaxi Pharmaceutical Co., Ltd. Recent Developments
  127. 6.22 Beijing Baoshutang Technology Pharmaceutical Co., Ltd.
  128. 6.22.1 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Company Information
  129. 6.22.2 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Business Overview
  130. 6.22.3 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Kangerxin Capsules Product Portfolio
  132. 6.22.5 Beijing Baoshutang Technology Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Kangerxin Capsules Sales by Country
  2. 7.1.1 North America Kangerxin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kangerxin Capsules Sales by Country (2021-2026)
  4. 7.1.3 North America Kangerxin Capsules Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kangerxin Capsules Market Size by Country
  6. 7.2.1 North America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kangerxin Capsules Market Size by Country (2021-2026)
  8. 7.2.3 North America Kangerxin Capsules Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kangerxin Capsules Sales by Country
  2. 8.1.1 Europe Kangerxin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kangerxin Capsules Sales by Country (2021-2026)
  4. 8.1.3 Europe Kangerxin Capsules Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kangerxin Capsules Market Size by Country
  6. 8.2.1 Europe Kangerxin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kangerxin Capsules Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kangerxin Capsules Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kangerxin Capsules Sales by Country
  2. 9.1.1 Asia-Pacific Kangerxin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kangerxin Capsules Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kangerxin Capsules Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kangerxin Capsules Market Size by Country
  6. 9.2.1 Asia-Pacific Kangerxin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kangerxin Capsules Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kangerxin Capsules Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kangerxin Capsules Sales by Country
  2. 10.1.1 South America Kangerxin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kangerxin Capsules Sales by Country (2021-2026)
  4. 10.1.3 South America Kangerxin Capsules Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kangerxin Capsules Market Size by Country
  6. 10.2.1 South America Kangerxin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kangerxin Capsules Market Size by Country (2021-2026)
  8. 10.2.3 South America Kangerxin Capsules Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kangerxin Capsules Sales by Country
  2. 11.1.1 Middle East and Africa Kangerxin Capsules Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kangerxin Capsules Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kangerxin Capsules Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kangerxin Capsules Market Size by Country
  6. 11.2.1 Middle East and Africa Kangerxin Capsules Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kangerxin Capsules Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kangerxin Capsules Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kangerxin Capsules Value Chain Analysis
  2. 12.1.1 Kangerxin Capsules Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kangerxin Capsules Production Mode & Process
  7. 12.2 Kangerxin Capsules Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kangerxin Capsules Distributors
  10. 12.2.3 Kangerxin Capsules Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst